Free shipping on orders over $99
STAT Inhibitors in Cancer

STAT Inhibitors in Cancer

by Alister C. Ward
Hardback
Publication Date: 17/10/2016

Share This Book:

  $310.47
or 4 easy payments of $77.62 with
afterpay
This item qualifies your order for FREE DELIVERY
This volume, which includes contributions from leading scientists and clinicians in the field, provides definitive, state-of-the-art information on STAT inhibitors in a biological and clinical context. It gives an overview of the biology of the STAT family of transcription factors and their role in cancer etiology. Additionally, it describes the raft of therapeutic approaches being used to inhibit STATs in the context of various cancers, covering the full spectrum of therapeutic approaches to inhibiting STATs, and presenting emerging data from clinical trials.
ISBN:
9783319429472
9783319429472
Category:
Oncology
Format:
Hardback
Publication Date:
17-10-2016
Publisher:
Birkhauser Verlag AG
Country of origin:
Switzerland
Pages:
195
Dimensions (mm):
235x155x13mm
Weight:
4.32kg

This title is in stock with our Australian supplier and should arrive at our Sydney warehouse within 2 - 3 weeks of you placing an order.

Once received into our warehouse we will despatch it to you with a Shipping Notification which includes online tracking.

Please check the estimated delivery times below for your region, for after your order is despatched from our warehouse:

ACT Metro: 2 working days
NSW Metro: 2 working days
NSW Rural: 2-3 working days
NSW Remote: 2-5 working days
NT Metro: 3-6 working days
NT Remote: 4-10 working days
QLD Metro: 2-4 working days
QLD Rural: 2-5 working days
QLD Remote: 2-7 working days
SA Metro: 2-5 working days
SA Rural: 3-6 working days
SA Remote: 3-7 working days
TAS Metro: 3-6 working days
TAS Rural: 3-6 working days
VIC Metro: 2-3 working days
VIC Rural: 2-4 working days
VIC Remote: 2-5 working days
WA Metro: 3-6 working days
WA Rural: 4-8 working days
WA Remote: 4-12 working days

You can find this item in:

Show more Show less

Reviews

Be the first to review STAT Inhibitors in Cancer.